Literature DB >> 27697764

Breaking the Permeability Barrier of Escherichia coli by Controlled Hyperporination of the Outer Membrane.

Ganesh Krishnamoorthy1, David Wolloscheck1, Jon W Weeks1, Cameron Croft1, Valentin V Rybenkov1, Helen I Zgurskaya2.   

Abstract

In Gram-negative bacteria, a synergistic relationship between slow passive uptake of antibiotics across the outer membrane and active efflux transporters creates a permeability barrier, which efficiently reduces the effective concentrations of antibiotics in cells and, hence, their activities. To analyze the relative contributions of active efflux and the passive barrier to the activities of antibiotics, we constructed Escherichia coli strains with controllable permeability of the outer membrane. The strains expressed a large pore that does not discriminate between compounds on the basis of their hydrophilicity and sensitizes cells to a variety of antibacterial agents. We found that the efficacies of antibiotics in these strains were specifically affected by either active efflux or slow uptake, or both, and reflect differences in the properties of the outer membrane barrier, the repertoire of efflux pumps, and the inhibitory activities of antibiotics. Our results identify antibiotics which are the best candidates for the potentiation of activities through efflux inhibition and permeabilization of the outer membrane.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27697764      PMCID: PMC5119019          DOI: 10.1128/AAC.01882-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

Review 1.  AcrAB and related multidrug efflux pumps of Escherichia coli.

Authors:  H Nikaido; H I Zgurskaya
Journal:  J Mol Microbiol Biotechnol       Date:  2001-04

2.  Diffusion through channel derivatives of the Escherichia coli FhuA transport protein.

Authors:  Michael Braun; Helmut Killmann; Elke Maier; Roland Benz; Volkmar Braun
Journal:  Eur J Biochem       Date:  2002-10

Review 3.  Molecular basis of bacterial outer membrane permeability revisited.

Authors:  Hiroshi Nikaido
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

Review 4.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

5.  AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex.

Authors:  Elena B Tikhonova; Helen I Zgurskaya
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

6.  Redesign of a plugged beta-barrel membrane protein.

Authors:  Mohammad M Mohammad; Khalil R Howard; Liviu Movileanu
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

7.  Outer membranes of gram-negative bacteria are permeable to steroid probes.

Authors:  P Plésiat; H Nikaido
Journal:  Mol Microbiol       Date:  1992-05       Impact factor: 3.501

Review 8.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

9.  Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It.

Authors:  Helen I Zgurskaya; Cesar A Löpez; S Gnanakaran
Journal:  ACS Infect Dis       Date:  2015       Impact factor: 5.084

10.  Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria.

Authors:  Elena B Tikhonova; Quiju Wang; Helen I Zgurskaya
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

View more
  46 in total

1.  Spectrofluorimetric quantification of antibiotic drug concentration in bacterial cells for the characterization of translocation across bacterial membranes.

Authors:  Julia Vergalli; Estelle Dumont; Jelena Pajović; Bertrand Cinquin; Laure Maigre; Muriel Masi; Matthieu Réfrégiers; Jean-Marie Pagés
Journal:  Nat Protoc       Date:  2018-05-17       Impact factor: 13.491

2.  Second-generation aryl isonitrile compounds targeting multidrug-resistant Staphylococcus aureus.

Authors:  Kwaku Kyei-Baffour; Haroon Mohammad; Mohamed N Seleem; Mingji Dai
Journal:  Bioorg Med Chem       Date:  2019-03-19       Impact factor: 3.641

3.  First-generation structure-activity relationship studies of 2,3,4,9-tetrahydro-1H-carbazol-1-amines as CpxA phosphatase inhibitors.

Authors:  Yangxiong Li; Jessi J Gardner; Katherine R Fortney; Inga V Leus; Vincent Bonifay; Helen I Zgurskaya; Alexandre A Pletnev; Sheng Zhang; Zhong-Yin Zhang; Gordon W Gribble; Stanley M Spinola; Adam S Duerfeldt
Journal:  Bioorg Med Chem Lett       Date:  2019-05-06       Impact factor: 2.823

Review 4.  Defining new chemical space for drug penetration into Gram-negative bacteria.

Authors:  Shibin Zhao; Justyna W Adamiak; Vincent Bonifay; Jitender Mehla; Helen I Zgurskaya; Derek S Tan
Journal:  Nat Chem Biol       Date:  2020-11-16       Impact factor: 15.040

5.  A "Drug Sweeping" State of the TriABC Triclosan Efflux Pump from Pseudomonas aeruginosa.

Authors:  Lucien Fabre; Abigail T Ntreh; Amira Yazidi; Inga V Leus; Jon W Weeks; Sudipta Bhattacharyya; Jakob Ruickoldt; Isabelle Rouiller; Helen I Zgurskaya; Jurgen Sygusch
Journal:  Structure       Date:  2020-09-22       Impact factor: 5.006

6.  Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold.

Authors:  Adam T Green; Mohammad Moniruzzaman; Connor J Cooper; John K Walker; Jeremy C Smith; Jerry M Parks; Helen I Zgurskaya
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-02-04       Impact factor: 3.770

7.  Drug Permeation against Efflux by Two Transporters.

Authors:  Paramita Saha; Samapan Sikdar; Ganesh Krishnamoorthy; Helen I Zgurskaya; Valentin V Rybenkov
Journal:  ACS Infect Dis       Date:  2020-02-25       Impact factor: 5.084

8.  Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa.

Authors:  Connor J Cooper; Ganesh Krishnamoorthy; David Wolloscheck; John K Walker; Valentin V Rybenkov; Jerry M Parks; Helen I Zgurskaya
Journal:  ACS Infect Dis       Date:  2018-05-25       Impact factor: 5.084

Review 9.  The Evolutionary Conservation of Escherichia coli Drug Efflux Pumps Supports Physiological Functions.

Authors:  Tanisha Teelucksingh; Laura K Thompson; Georgina Cox
Journal:  J Bacteriol       Date:  2020-10-22       Impact factor: 3.490

10.  Kinetic Control of Quorum Sensing in Pseudomonas aeruginosa by Multidrug Efflux Pumps.

Authors:  David Wolloscheck; Ganesh Krishnamoorthy; Jennifer Nguyen; Helen I Zgurskaya
Journal:  ACS Infect Dis       Date:  2017-11-10       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.